Sharon Hrynkow Biography and Net Worth

Dr. Hrynkow joined the Company in September 2015.  Prior to joining Cyclo Therapeutics, Dr. Hrynkow served in a range of leadership roles in global health at the National Institutes of Health (NIH), including as Deputy Director and Acting Director of the Fogarty International Center, Associate Director of the National Institute on Environmental Health Sciences, and Senior Advisor to the NIH Deputy Director.  She also made seminal contributions in the fight against HIV/AIDS during her early federal service at the Department of State.  In 2012, Dr. Hrynkow became the inaugural President of the Global Virus Network, a non-profit organization working to combat pandemic viral disease.

A developmental neuroscientist by training, Dr. Hrynkow has worked passionately for decades to advance science for the benefit of society, to now include her work at Cyclo Therapeutics to bring Trappsol® Cyclo™ to market approval for the benefit of patients suffering from Niemann-Pick Disease type C and Alzheimer’s Disease. She is frequently asked to serve on national and international advisory committees, and has served on the President’s Council of Advisors for Science and Technology, American Association for the Advancement of Science Committee on Science, Engineering and Public Policy (also as Chair) and the U.S. National Academies of Science, Engineering and Medicine’s Division of Earth and Life Sciences advisory committee.  She has been recognized for her contributions to global health and global science through prestigious awards, including with the US President’s Merit Award for Senior Executives, the Order of Merit from the King of Norway, and as an elected Fellow of the American Association for the Advancement of Science and as an elected member of the Council on Foreign Relations.